flumazenil has been researched along with Pain, Chronic in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Regional gray matter alterations in chronic pain, as detected with voxel-based morphometry of anatomical magnetic resonance images, are commonly interpreted to reflect neurodegeneration, but this assumption has not been tested." | 1.46 | Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging. ( Araujo, D; Ceko, M; Daigle-Martel, A; Feier, NA; Fitzcharles, MA; Funck, T; Narayanan, S; Pomares, FB; Roy, S; Schweinhardt, P; Stikov, N; Thiel, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pomares, FB | 1 |
| Funck, T | 1 |
| Feier, NA | 1 |
| Roy, S | 1 |
| Daigle-Martel, A | 1 |
| Ceko, M | 1 |
| Narayanan, S | 1 |
| Araujo, D | 1 |
| Thiel, A | 1 |
| Stikov, N | 1 |
| Fitzcharles, MA | 1 |
| Schweinhardt, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Investigation of the Effect of Initial Central Sensitization Severity on Treatment Response in Patients With Fibromyalgia[NCT05020600] | 40 participants (Anticipated) | Observational | 2021-08-19 | Recruiting | |||
| Investigation of the Relationship Between Neuropathic Complaints and Central Sensitization in Patients With Fibromyalgia[NCT05701696] | 111 participants (Anticipated) | Observational | 2023-01-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for flumazenil and Pain, Chronic
| Article | Year |
|---|---|
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |